Dedicated to Global Product Safety, Brand Loyalty, and Patient Access Strategies that Support the Full Product Lifecycle
Who We Are
United BioSource Corporation (UBC) is a leading provider of pharmaceutical support services, partnering with life science companies to make medicine and medical products safer and more accessible. Our diverse suite of services helps bridge the gap between development and delivery and builds brand loyalty through patient access and adherence.
UBC is well known for our ability to generate authoritative, real-world evidence of product effectiveness, safety, and value to assist healthcare decisions and enhance patient care.
With the strength of our parent company, Express Scripts, one of the nation’s largest healthcare companies, UBC leads the market in providing integrated, comprehensive clinical, safety, and commercialization services. Working hand-in-hand with Express Scripts’ specialty pharmacy and specialty distribution organizations, Accredo and CuraScript SD, UBC is uniquely positioned to seamlessly integrate best-in-class services throughout the lifecycle of a product.
Developing a drug, taking it through commercialization, and demonstrating its post-launch value and safety is a complex journey. Regulatory hurdles and payer decision-making are increasing the complexity around drug development and product choices. UBC has aligned our expertise and industry insight to help manufacturers make informed decisions early in the product journey that ultimately optimize care and improve patient outcomes.
The most successful product journeys start with great maps. UBC’s industry-leading experts work in unison to effectively navigate the product lifecycle, focusing on:
We understand what it takes to compete in a crowded product market with many stakeholders that demand the right evidence at the right time.
Our Past, Present, and Our Future
UBC was founded in 2003 by industry experts with a passion for innovation and a commitment to working with pharmaceutical and biotech organizations in proving the safety, efficacy, and value of pharmaceutical and medical products. We recognized the opportunity to build an organization tailored to meet the need for scientific evidence in the healthcare industry. And, we quickly developed our core strength – the generation, analysis, and communication of real-world evidence throughout the product lifecycle.
UBC is now part of Express Scripts. Our goal to support manufacturer sponsors with the best possible team of recognized scientific and industry experts and leading technology is backed by a parent company that manages more than a billion prescriptions a year for tens of millions of patients.
By combining insight from data, understanding patient behavior, and the science behind clinical specialties, we can help our clients make informed decisions and optimize the care given to patients using their therapies and products.
Firewall Policy: To ensure the independence of UBC’s contracted work with pharmaceutical/medical device manufacturers and to protect the integrity of its parent company’s clinical and formulary decisions, there is a firewall between UBC’s pharmaceutical/medical device services business and the pharmacy benefit management (“PBM”) business. UBC will not be influenced by any rebate or other related agreements with pharmaceutical/medical device manufacturers. Similarly, transactions between pharmaceutical/medical device manufacturers and UBC will not affect PBM clinical and formulary decisions.